Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 18, 2024: Archives of Disease in Childhood
#2
Radhika Rathi, Pallavi Harjpal
Miller Fisher syndrome is a rare and atypical variation of Guillain-Barré syndrome, which includes the clinical triad of areflexia, ataxia, and ophthalmoplegia. Miller Fisher syndrome is commonly associated with the involvement of the lower cranial and facial nerves. Miller Fisher syndrome is one of the types of Guillain-Barré syndrome. Guillain-Barré syndrome has been defined to be the foremost incapacitating form of neurological disease following the disease polio. Guillain-Barré syndrome is a broad category that encompasses several types of acute immune-mediated polyneuropathies, the most common of which is acute inflammatory demyelinating polyradiculoneuropathy...
March 2024: Curēus
#3
JOURNAL ARTICLE
Tauseef Ahmad, Mukhtiar Baig, Muhammad Khan
No abstract text is available yet for this article.
March 2024: Journal of Virus Eradication
#4
JOURNAL ARTICLE
Yuming Sun, Pinar Keskinocak, Lauren N Steimle, Stephanie D Kovacs, Steven G Wassilak
BACKGROUND: Despite the successes of the Global Polio Eradication Initiative, substantial challenges remain in eradicating the poliovirus. The Sabin-strain (live-attenuated) virus in oral poliovirus vaccine (OPV) can revert to circulating vaccine-derived poliovirus (cVDPV) in under-vaccinated communities, regain neurovirulence and transmissibility, and cause paralysis outbreaks. Since the cessation of type 2-containing OPV (OPV2) in 2016, there have been cVDPV type 2 (cVDPV2) outbreaks in four out of six geographical World Health Organization regions, making these outbreaks a significant public health threat...
June 2024: Vaccine: X
#5
JOURNAL ARTICLE
Imtiaz Hussain, Muhammad Umer, Ahmad Khan, Muhammad Sajid, Imran Ahmed, Kehkashan Begum, Junaid Iqbal, Muhammad M Alam, Rana M Safdar, Shahzad Baig, Arie Voorman, Jeffrey Partridge, Sajid Soofi
INTRODUCTION: After trivalent oral poliovirus vaccine (tOPV) cessation, Pakistan has maintained immunity to type 2 poliovirus by administering inactivated polio vaccine (IPV) in routine immunization, alongside monovalent OPV type 2 (mOPV2) and IPV in supplementary immunization activities (SIAs). This study assesses the change in poliovirus type 2 immunity after tOPV withdrawal and due to SIAs with mOPV2 and IPV among children aged 6-11 months. METHODS: Three cross-sectional sequential serological surveys were conducted in 12 polio high-risk areas of Pakistan...
2024: Frontiers in Public Health
#6
JOURNAL ARTICLE
Zaeem Ul Haq, Soofia Yunus, Naveed Jafri
In a health emergency, governments rely on public trust in their policy, and anticipate its compliance to protect health and save lives. Vaccine hesitancy compromises this process when an emergency involves infections. The prevailing discourse on vaccine hesitancy often describes it as a static phenomenon, ignoring its expanse and complexity, and neglecting the exploration of tools to address it. This article diverges from the conventional perspective by explaining the case of Pakistan and its communication strategy for the COVID-19 vaccine...
April 10, 2024: BMJ Global Health
#7
JOURNAL ARTICLE
Wrishmeen Sabawoon, Shion Seino, Bakht Mohmmad Pason, Nek Wali Shah Momin, Sayako Kanamori, Connor Bender, Kazuhisa Takemura
BACKGROUND: Warfare has long impeded vaccination programs in polio-endemic Afghanistan. We aimed to describe progress in access to children under 5, oral polio vaccine (OPV) coverage among children under 5 in nationwide polio campaigns, and polio surveillance performance indicators after the Islamic Republic of Afghanistan collapsed to Taliban forces in August 2021. METHODS: Trends in the number of wild poliovirus type 1 (WPV1) and circulating vaccine-derived poliovirus type 2 (cVDPV2) cases and surveillance indicators from 2015 to 2023, and trends in the OPV coverage in the November 2020-June 2022 polio campaigns, were described...
April 10, 2024: Journal of Infectious Diseases
#8
JOURNAL ARTICLE
T Jacob John, Dhanya Dharmapalan, Robert Steinglass, Norbert Hirschhorn
No abstract text is available yet for this article.
April 15, 2024: Indian Pediatrics
#9
JOURNAL ARTICLE
Kerstin Unfried, Jan Priebe
The widespread dissemination of misinformation on social media is a serious threat to global health. To a large extent, it is still unclear who actually shares health-related misinformation deliberately and accidentally. We conducted a large-scale online survey among 5,307 Facebook users in six sub-Saharan African countries, in which we collected information on sharing of fake news and truth discernment. We estimate the magnitude and determinants of deliberate and accidental sharing of misinformation related to three vaccines (HPV, polio, and COVID-19)...
2024: PloS One
#10
JOURNAL ARTICLE
Salsbeel Khan, Iqra Hamid Khan, Tahira Ashraf
OBJECTIVES: To study the impact of coronavirus disease-2019 on Expanded Programme on Immunisation in a rural setting. METHODS: The descriptive, cross-sectional study was conducted in five union councils of District Dir Lower, in the Khyber Pakhtunkhwa province of Pakistan. Data was collected from March to August 2020, which was a period of lockdowns in the wake of the coronavirus disease-2019, and then from March to August 2021. The sample comprised children aged <2 years...
March 2024: JPMA. the Journal of the Pakistan Medical Association
#11
JOURNAL ARTICLE
Charles Byabamazima, Brine Masvikeni, Reggis Katsande, Daudi Manyanga
INTRODUCTION: the Africa region was certified indigenous wild poliovirus-free in August 2020. Countries in East and Southern Africa have, during acute flaccid paralysis (AFP) and environmental surveillance (ES), detected equally concerning vaccine-derived polioviruses (VDPVs) that have not been systematically documented to guide programming in the sub-region. The study documents trends and salient observations of the VDPVs by country of detection, for 11 years from 2010 to 2021. METHODS: we conducted secondary data analysis, a descriptive study design, by deploying field and laboratory of AFP and environmental surveillance databases of the 20 East and Southern African countries from 2010 to 2021...
2024: Pan African Medical Journal
#12
JOURNAL ARTICLE
Takashi Nakano, Masumi Hasegawa, Mai Endo, Keiko Matsuda, Hoshio Tamai
OBJECTIVE: This study investigated the immunogenicity and safety of a pentavalent vaccine Gobik (DPT-IPV-Haemophilus influenzae type b [Hib]) in healthy Japanese infants aged ≥ 2 and < 43 months using a concomitant vaccination with ActHIB® (Hib) and Tetrabik (DPT-IPV) as a comparator. METHODS: This study was conducted as a phase 3, multicenter, active controlled, assessor-blinded, randomized, parallel-group study. Participants received a total of 4 subcutaneous doses (3 primary immunization doses and a booster dose) of either the experimental drug (DPT-IPV-Hib) or the active comparator (Hib + DPT-IPV)...
April 5, 2024: Vaccine
#13
JOURNAL ARTICLE
Nishant Kishore, Elizabeth Krow-Lucal, Ousmane M Diop, Jaume Jorba, Tigran Avagnan, Varja Grabovac, Anfumbom K W Kfutwah, Ticha Johnson, Sudhir Joshi, Lucky Sangal, Salmaan Sharif, Ashraf Wahdan, Graham F Tallis, Stephanie D Kovacs
The reliable and timely detection of poliovirus cases through surveillance for acute flaccid paralysis (AFP), supplemented by environmental surveillance of sewage samples, is a critical component of the polio eradication program. Since 1988, the number of polio cases caused by wild poliovirus (WPV) has declined by >99.9%, and eradication of WPV serotypes 2 and 3 has been certified; only serotype 1 (WPV1) continues to circulate, and transmission remains endemic in Afghanistan and Pakistan. This surveillance update evaluated indicators from AFP surveillance, environmental surveillance for polioviruses, and Global Polio Laboratory Network performance data provided by 28 priority countries for the program during 2022-2023...
April 4, 2024: MMWR. Morbidity and Mortality Weekly Report
#14
JOURNAL ARTICLE
Ananda S Bandyopadhyay, Rachel M Burke, Kaija M Hawes
No abstract text is available yet for this article.
April 2, 2024: Pediatric Infectious Disease Journal
#15
JOURNAL ARTICLE
Carlos A Emanuele, Anne E Jean Baptiste, Ana E Chévez, Mirta Magarinos, Maite V Antelo, Sonia Arza, Emilia Cain, Gloria Rey-Benito, Martha Velandia-Gonzalez, Daniel Salas
The Pan American Health Organization (PAHO) and its Member States have been leading the efforts to eradicate wild poliovirus in the Region of Americas since smallpox's successful elimination in 1971. The region became the first to be certified free of wild poliovirus in 1994. However, in July 2022, an unvaccinated patient with no recent travel history was diagnosed with poliomyelitis in the United States of America. In response to the emergence of a circulating vaccine-derived poliovirus in the United States, PAHO established the Polio Incident Management Support Team...
2024: Pan American Journal of Public Health
#16
REVIEW
Angelina Zarzeczny, Payal Kahar
Pakistan bears an incredible burden of vaccine-preventable diseases, and efforts to improve widespread immunization have been hindered by inadequate public health management following disasters and other health emergencies. Through a brief review of Pakistan's health system, an understanding of routine immunization challenges is sought based on the organizational changes made to the planning and delivery of immunization activities. Further, recent immunization trends of measles, polio, and tuberculosis are examined in correspondence to health emergencies prompted by climate change and the COVID-19 pandemic...
March 2024: Curēus
#17
JOURNAL ARTICLE
Hsiuying Wang
BACKGROUND: Anti-N-methyl-d-aspartate (Anti-NMDA) receptor encephalitis is a rare autoimmune disease, which is caused by antibodies attacking NMDA receptors in the brain. Previous studies revealed that this disorder might be induced by vaccination. Vaccination is the most useful strategy to prevent human or animal infectious diseases. MATERIALS AND METHODS: Although vaccines can produce immunity against diseases, at low risk, they may trigger serious adverse events...
February 16, 2024: Current Medicinal Chemistry
#18
JOURNAL ARTICLE
Claudia Gaviria-Agudelo, Alexandra B Yonts, David W Kimberlin, James D Campbell, Grant C Paulsen, Sean T O'Leary
The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts that provides advice to the Centers for Disease Control and Prevention, normally meets 3 times per year to develop US vaccine recommendations. The ACIP met February 28 to 29, 2024, to discuss coronavirus disease (COVID-19) vaccines, chikungunya vaccines, DT vaccine, influenza vaccines, polio vaccines, RSV vaccines, meningococcal vaccines, pneumococcal vaccines and Vaxelis (DTaP, Inactivated Poliovirus, Haemophilus influenzae b Conjugate & Hepatitis B Vaccine)...
March 29, 2024: Pediatrics
#19
JOURNAL ARTICLE
Margarida Pires Simoes, Emma B Hodcroft, Peter Simmonds, Jan Albert, Enagon K Alidjinou, Katia Ambert-Balay, Cristina Andrés, Andrés Antón, Christelle Auvray, Jean-Luc Bailly, Fausto Baldanti, Capser Bastings, Stuart Beard, Carla Berengua Pereira, Natasa Berginc, Mandy Bloemen, Soile Blomqvist, Froukje Bosma, Sindy Böttcher, Laura Bubba, Stafan Buderus, Maria Cabrerizo, Christina Calvo, Christina Celma, Ferruccio Ceriotti, Gemma Clark, Inës Costa, Marianne Coste-Burel, Karen Couderé, Jeroen Cremer, Margarita Del Cuerpo Casas, Theo Daehne, Jessica de Beer, Maria de Ceano-Vivas, Cillian De Gascun, Alexis de Rougemont, Johnathan Dean, Jennifer L Dembinski, Sabine Diedrich, Javier Diez-Domingo, Lena Dillner, Dagny H Dorenberg, Alexandra Ducancelle, Susanne Dudman, Robert Dyrdak, Anna-Maria Eis-Huebinger, Iker Falces-Romero, Agnes Farkas, Susan Feeney, Maria D Fernandez-Garcia, Jacky Flipse, Kristina T Franck, Cristina Galli, Isabelle Garrigue, Felix Geeraedts, Irina Georgieva, Federica Giardina, Raquel Guiomar, Elenor Hauzenberger, Esther Heikens, Cécille Henquell, Didier Hober, Amrio Hönemann, Hannah Howson-Wells, Željka Hruškar, Niina Ikonen, Berthemarie Imbert, Arjan R Jansz, Marion Jeannoël, Helena Jiřincová, Laurence Josset, Kathrin Keeren, Naomie Kramer-Lindhout, Sidsel Krokstad, Mouna Lazrek, Hélène Le Guillou-Guillemette, Caroline Lefeuvre, Andreas Lind, Maja M Lunar, Melanie Maier, Stéphanie Marque-Juillet, C Patrick McClure, James McKenna, Adam Meijer, Ana Menasalvas Ruiz, Beatriz Mengual-Chuliá, Sofie Midgley, Audrey Mirand, Richard Molenkamp, Milagrosa Montes, Antonio Moreno-Docón, Ursula Morley, Jean-Luc Murk, Ana Navascués-Ortega, Roel Nijhuis, Lubomira Nikolaeva-Glomb, Svein A Nordbø, Sanela Numanovic, Massimo Oggioni, Eider Oñate Vergara, Jordi Pacaud, Marie L Pacreau, Marcus Panning, Elena Pariani, Lili Pekova, Laura Pellegrinelli, Miroslav Petrovec, Corinna Pietsch, Léa Pilorge, Luis Piñeiro, Antonio Piralla, Mario Poljak, Birgit Prochazka, Nuria Rabella, Janette C Rahamat-Langendoen, Petra Rainetova, Marijke Reynders, Annelies Riezebos-Brilman, Lieuwe Roorda, Carita Savolainen-Kopra, Isabelle Schuffenecker, Leo C Smeets, Ayse Stoyanova, Karl Stefic, Caroline Swanink, Irena Tabain, Jeroen Tjhie, Luc Thouault, Camille Tumiotto, Sara Uceda Renteria, Tina Uršič, Sophie Vallet, Marc Van Ranst, Peter Van Wunnik, Jaco J Verweij, Jorgina Vila, Bas Wintermans, Elke Wollants, Katja C Wolthers, F Xavier López-Labrado, Thea Kolsen Fischer, Heli Harvala, Kimberley S M Benschop
Enterovirus D68 (EV-D68) infections are associated with severe respiratory disease and acute flaccid myelitis (AFM). The European Non-Polio Enterovirus Network (ENPEN) aimed to investigate the epidemiological and genetic characteristics of EV-D68 and its clinical impact during the fall-winter season of 2021/22. From 19 European countries, 58 institutes reported 10,481 (6.8%) EV-positive samples of which 1,004 (9.6%) were identified as EV-D68 (852 respiratory samples). Clinical data was reported for 969 cases...
March 28, 2024: Journal of Infectious Diseases
#20
JOURNAL ARTICLE
Megan Halbrook, Adva Gadoth, Patrick Mukadi, Nicole A Hoff, Kamy Musene, Camille Dzogang, Cyrus Shannon Sinai, D'Andre Spencer, Guillaume Ngoie-Mwamba, Sylvia Tangney, Frank Salet, Michel Nyembwe, Michel Kambamba Nzaji, Merly Tambu, Placide Mbala, Trevon Fuller, Sue K Gerber, Didine Kaba, Jean Jacques Muyembe-Tamfum, Anne W Rimoin
Despite the successes in wild-type polio eradication, poor vaccine coverage in the DRC has led to the occurrence of circulating vaccine-derived poliovirus outbreaks. This cross-sectional population-based survey provides an update to previous poliovirus-neutralizing antibody seroprevalence studies in the DRC and quantifies risk factors for under-immunization and parental knowledge that guide vaccine decision making. Among the 964 children between 6 and 35 months in our survey, 43.8% (95% CI: 40.6-47.0%), 41...
February 27, 2024: Vaccines
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
